Phase II Study of Simvastatin in Waldenstrom's Macroglobulinemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Simvastatin (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 Biomarkers information updated
- 23 Jun 2011 Planned End Date changed from 1 Aug 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 20 May 2010 Planned end date changed from Dec 2009 to Aug 2010 as reported by ClinicalTrials.gov.